| 异环磷酰胺联合化疗治疗晚期非小细胞肺癌近期疗效 |
| |
| 引用本文： | 余萍,王更利,李秋. 异环磷酰胺联合化疗治疗晚期非小细胞肺癌近期疗效[J]. 中国医药导刊, 2000, 2(2): 47-48 |
| |
| 作者姓名： | 余萍 王更利 李秋 |
| |
| 作者单位： | [1]四川省肿瘤医院内科,成都 [2]四川省肿瘤医院药剂科,成都 |
| |
| 摘 要： | ４０例晚期非小细胞肺癌患,经用ＩＦＯ＋ＤＤＰ或ＩＦＯ＋ＶＰ－１６治疗,２例ＣＲ（５％）,１７例ＰＲ（４２．５％）,ＣＲ＋ＰＲ为４７．５％（１９／４０）。毒性反应主要是骨髓抑制和消化道症状。结果揭示含异环磷酰胺的联合化疗治疗晚期非小细胞肺癌疗效较好,有一定程度骨髓抑制,配合Ｇ－ＣＳＦ治疗恢复较快。
|
| 关 键 词： | 异环磷酰胺 非小细胞肺癌 联合化疗 疗效 |
The Preliminary Result for the Treatment of Advanced Non - small Cell Lung Cancer with Ifosfamide Containing Regimens |
| |
| Yu Ping,Wang Geng - li,Li Qiu,Wan Xin. The Preliminary Result for the Treatment of Advanced Non - small Cell Lung Cancer with Ifosfamide Containing Regimens[J]. Chinese Journal of Medicinal Guide, 2000, 2(2): 47-48 |
| |
| Authors: | Yu Ping Wang Geng - li Li Qiu Wan Xin |
| |
| Affiliation: | Yu Ping,Wang Geng-li,Li Qiu,Wan Xin(Sichuan Cancer Hospital, Chengdu 61004) |
| |
| Abstract: | 40 Cases of advanced non - small cell lung cancer were treated with ifosfamide plus cisplatin regimen versus ifosfamide plus etoposide regimen. The result showed 2 cases CR(5% ), 17cases PR(42. 5% ), CR + PR 47.5% (19/40) . Major toxicity was myelosuppression and gastrointestial reaction. Thus, ifosfamide containing regimens may be selected as effective regimen in advanced NSCLC. |
| |
| Keywords: | ifosfamide non - small cell lung cancer combined chemotherapy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
